Tag: Antibody
Demand for COVID antibody drugs soars in hard-hit states – Press...
People infected with COVID-19 were captured in a photo this week lying on the floor in pain while waiting for antibody infusions at...
Thermo Fisher Scientific (US) and GenScript (US) are the Prominent Players...
The global custom antibody market is projected to reach USD 652 million by 2026 from USD 393 million in 2021, at a CAGR...
aTyr Pharma Presents Poster Demonstrating Functional Selectivity of Second Anti-NRP2 Antibody
Preclinical candidate is second to demonstrate selective blocking ability from in-house panel of antibodies targeting NRP2. aNRP2-14...
IGM Biosciences Announces Expansion of IgM Platform into Infectious Diseases, Publication...
MOUNTAIN VIEW, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) a clinical-stage biotechnology company focused on creating...
Agenus to Host Conference Call to Discuss Global Licensing Agreement with...
LEXINGTON, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies,...
Diazyme Laboratories, Inc. Announces CE-IVD for its Semi-Quantitative SARS-CoV-2 Neutralizing Antibody...
SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. announced March 30th that it has obtained CE-IVD marking for...
GTX Corp Begins Exporting Hearing Related Products and Rapid Antigen and...
LOS ANGELES, CALIFORNIA, March 25, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the...
Lee’s Pharmaceutical Announces its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics,...
Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee’s Pharm.China’s National Medical Products Administration (“NMPA”) clears Lee’s...